Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.

Chi Cheng Huang, Shih Hsin Tu, Heng Hui Lien, Jaan Yeh Jeng, Jung Sen Liu, Ching Shui Huang, Yih Yiing Wu, Chih Yi Liu, Liang Chuan Lai, Eric Y. Chuang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. For Sørlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed.

Original languageEnglish
Article numberS10
JournalJournal of Translational Medicine
Volume10 Suppl 1
Publication statusPublished - Sep 19 2012
Externally publishedYes

Fingerprint

Genes
Breast Neoplasms
Population
Gene expression
Tumors
Microarrays
Phenobarbital
Aberrations
Decision making
Taiwan
Transcriptome
China
Decision Making
Prospective Studies
Gene Expression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Huang, C. C., Tu, S. H., Lien, H. H., Jeng, J. Y., Liu, J. S., Huang, C. S., ... Chuang, E. Y. (2012). Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population. Journal of Translational Medicine, 10 Suppl 1, [S10].

Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population. / Huang, Chi Cheng; Tu, Shih Hsin; Lien, Heng Hui; Jeng, Jaan Yeh; Liu, Jung Sen; Huang, Ching Shui; Wu, Yih Yiing; Liu, Chih Yi; Lai, Liang Chuan; Chuang, Eric Y.

In: Journal of Translational Medicine, Vol. 10 Suppl 1, S10, 19.09.2012.

Research output: Contribution to journalArticle

Huang, CC, Tu, SH, Lien, HH, Jeng, JY, Liu, JS, Huang, CS, Wu, YY, Liu, CY, Lai, LC & Chuang, EY 2012, 'Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.', Journal of Translational Medicine, vol. 10 Suppl 1, S10.
Huang, Chi Cheng ; Tu, Shih Hsin ; Lien, Heng Hui ; Jeng, Jaan Yeh ; Liu, Jung Sen ; Huang, Ching Shui ; Wu, Yih Yiing ; Liu, Chih Yi ; Lai, Liang Chuan ; Chuang, Eric Y. / Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population. In: Journal of Translational Medicine. 2012 ; Vol. 10 Suppl 1.
@article{67f8df7c0fe14a33b91cefbd32efc7fb,
title = "Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.",
abstract = "Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (S{\o}rlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (S{\o}rlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. For S{\o}rlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed.",
author = "Huang, {Chi Cheng} and Tu, {Shih Hsin} and Lien, {Heng Hui} and Jeng, {Jaan Yeh} and Liu, {Jung Sen} and Huang, {Ching Shui} and Wu, {Yih Yiing} and Liu, {Chih Yi} and Lai, {Liang Chuan} and Chuang, {Eric Y.}",
year = "2012",
month = "9",
day = "19",
language = "English",
volume = "10 Suppl 1",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.

AU - Huang, Chi Cheng

AU - Tu, Shih Hsin

AU - Lien, Heng Hui

AU - Jeng, Jaan Yeh

AU - Liu, Jung Sen

AU - Huang, Ching Shui

AU - Wu, Yih Yiing

AU - Liu, Chih Yi

AU - Lai, Liang Chuan

AU - Chuang, Eric Y.

PY - 2012/9/19

Y1 - 2012/9/19

N2 - Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. For Sørlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed.

AB - Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. For Sørlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed.

UR - http://www.scopus.com/inward/record.url?scp=84877663232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877663232&partnerID=8YFLogxK

M3 - Article

C2 - 23046482

AN - SCOPUS:84877663232

VL - 10 Suppl 1

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - S10

ER -